Engaging hospitalized heroin-dependent patients into substance abuse treatment

Journal of Substance Abuse Treatment

Volumn 17, Issue 1-2, 1999, Pages 149-158

  Aszalos, Rita ^a   McDuff, David R ^a   Weintraub, Eric ^a   Montoya, Ivan ^a   Schwartz, Robert ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Heroin dependence; Linkage; Medical complications; Methadone treatment; Retention

Indexed keywords

METHADONE;

ARTICLE; COMPLICATION; DRUG WITHDRAWAL; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; METHADONE TREATMENT; PRIORITY JOURNAL; SUBSTANCE ABUSE; TREATMENT OUTCOME; URINALYSIS;

ADOLESCENT; ADULT; AMBULATORY CARE; FEMALE; HEROIN DEPENDENCE; HOSPITALIZATION; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PROGRAM EVALUATION; PSYCHOTHERAPY; SUBSTANCE ABUSE DETECTION; SUBSTANCE ABUSE TREATMENT CENTERS;

EID: 0032866701     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0740-5472(98)00075-0     Document Type: Article

References (72)

1. Alcabes P., Friedland G. Injection drug use and human immunodeficiency virus infection. Clinical Infectious Diseases. 20:1995;1467-1479.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 4th ed:1994;Author, Washington, DC.
3. Angell M., Kassirer J.P. Alcohol and other drugs - Toward a more rational and consistent policy. The New England Journal of Medicine. 331:1994;537-539.
4. Ball J., Lange R.W., Myers C.P., Freidman S.R. Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior. 29:1988;214-226.
5. Batki S.L., Bradley M., Jones T., Moon J., Schissel M., Masson C. A controlled trial of methadone treatment. Preliminary analysis of effects on medical care utilization [Abstract] Journal of Addictive Diseases. 17:1998;138.
6. Battjes, R.J., Leukefeld, C.G., & Amsel, Z. (1990). Community prevention efforts to reduce the spread of AIDS associated with intravenous drug abuse. In C.G. Leukefeld, R.J. Battjes, & Z. Amsel (Eds.), AIDS and intravenous drug use: Future directions for community-based prevention research. (NIDA Research Monograph No. 93, DHHS Publication No. ADM 90-1627). Rockville, MD: National Institute on Drug Abuse.
7. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry. 4:1961;561-571.
8. Boatler J.F., Knight K., Simpson D.D. Assessment of an AIDS intervention program during drug abuse treatment. Journal of Substance Abuse Treatment. 11:1994;367-372.
9. Bosshardt T.L., Henderson V.J., Organ C.H. Jr. Necrotizing soft-tissue infections. Archives of Surgery. 131:1996;846-854.
10. Brown L.S., Hickson M.J., Ajuluchukwu D.C., Bailey J. Medical disorders in a cohort of New York City drug abusers. much more than HIV disease Journal of Addictive Diseases. 12:1993;11-27.
11. Caiaffa W.T., Vlahov D., Graham N.M.H., Astemborski J., Solomon L., Nelson K.E., Munoz A. Drug smoking, pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. American Journal of Respiratory and Critical Care Medicine. 150:1994;1493-1498.
12. Caplehorn J.R.M., Dalton S.Y.N., Cluff M.C., Petrenas A. Retention in methadone maintenance and heroin addicts' risk of death. Addiction. 89:1994;203-207.
13. Chaisson R.E., Keruly J.C., Moore R.D. Race, sex, drug use, and progression of human immunodeficiency virus disease. The New England Journal of Medicine. 333:1995;751-755.
14. Cherubin C.E., Sapira J.D. The medical complications of drug addiction and the medical assessment of the intravenous drug user. 25 years later Annals of Internal Medicine. 119:1993;1017-1028.
15. Chitwood D.D., Griffin D.K., Comerford M., Page J.B., Trapido E.J., Lai S., McCoy C.B. Risk factors for HIV-1 seroconversion among injection drug users. A case-control study American Journal of Public Health. 85:1995;1538-1542.
16. Comer J.A., Flynn C., Regnery R.L., Vlahov D., Childs J. Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, MD. Archives of Internal Medicine. 156:1996;2491-2495.
17. Cooper J.R. Methadone treatment and acquired immunodeficiency syndrome. Journal of the American Medical Association. 262:1989;1664-1668.
18. D'Aunno T., Vaughn T.E. Variations in methadone treatment practices. Journal of the American Medical Association. 267:1992;253-258.
19. Dans P.E., Matricciani R.M., Otter S.E., Reuland D.S. Intravenous drug abuse and one academic medical center. Journal of the American Medical Association. 263:1990;3173-3176.
20. DeLeon G., Sacks S., Hilton R. Passages. A modified therapeutic community day treatment model for methadone clients Inciardi J.A., Tims F.M., Fletcher B.W. Innovative approaches in the treatment of drug abuse. Program models and strategies:1993;125-148 Greenwood Press, Westport, CT.
21. Dunn C.W., Ries R. Linking substance abuse services with general medical care. Intergrated, brief interventions with hospitalized patients American Journal of Drug and Alcohol Abuse. 23:1997;1-13.
22. Folstein J.F., Folstein S.E., McHugh P.R. "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician Journal of Psychiatry Research. 12:1975;189-198.
23. Foote J., Seligman M., Magura S., Handelsman L., Rosenblum A., Lovejoy M., Arrington K., Stimmel B. An enhanced positive reinforcement model for the severely impaired cocaine abuser. Journal of Substance Abuse Treatment. 11:1994;525-539.
24. Fox K., Merrill J.C., Chang H., Califano J.A. Estimating the cost of substance abuse to the Medicaid Hospital Care Program. American Journal of Public Health. 85:1995;48-54.
25. French M.T., Martin R.F. The costs of drug abuse consequences. A summary of research findings Journal of Substance Abuse Treatment. 13:1996;453-466.
26. Fuller M.G., Jordan M.L. The substance abuse consultation team - Addressing the problem of hospitalized substance abusers. General Hospital Psychiatry. 16:1994;73-77.
27. General Accounting Office. (1990). Report to the Chairman, Select Committee on Narcotics Abuse and Control, House of Representatives. Methadone maintenance: Some treatments are not effective; greater federal oversight needed (GAO/HRD-90-104). Washington, DC: Author.
28. Gottheil E., Sterling R.C., Weinstein S.P. Outreach engagement efforts. Are they worth the effort? American Journal of Drug and Alcohol Abuse. 23:1997;61-66.
29. Greenfield L., Brady J.V., Besteman K.J., De Smet A. Patient retention in mobile and fixed-site methadone maintenance treatment. Drug and Alcohol Dependence. 42:1996;125-131.
30. Gronbladh L., Ohlund L.S., Gunne L.M. Mortality in heroin addiction. Impact of methadone treatment Acta Psychiatrica Scandinavica. 82:1990;223-227.
31. Guydish J., Werdegar D., Tajima B., Price M., Acampora A. Clients entering drug abuse day treatment. 18-month outcomes American Journal of Drug and Alcohol Abuse. 23:1997;99-114.
32. Haverkos H.W. Infectious diseases and drug abuse. Prevention and treatment in the drug abuse treatment system Journal of Substance Abuse Treatment. 8:1991;269-275.
33. Haverkos H.W., Lange W.R. Serious infections other than human immunodeficiency virus among intravenous drug abusers. Journal of Infectious Disease. 161:1990;884-992.
34. Hirschtick R.E., Glassroth J., Jordan M.C., Timothy C.W., Wallace J.M., Kvale P.A., Markowitz N., Rosen M.J., Mangura B.T., Hopewell P.C., The Pulmonary Complications of HIV Infection Study Group Bacterial pneumonia in persons infected with the human immunodeficiency virus. The New England Journal of Medicine. 333:1995;845-851.
35. Hoffman J.A., Caudill B.D., Koman J.J. III, Luckey J.W., Flynn P.M., Hubbard R.L. Comparative cocaine abuse treatment strategies. enhancing client retention and treatment exposure Journal of Addictive Diseases. 13:1994;115-128.
36. Hoffmann N.G., DeHart S.S., Fulderson J.A. Medical care utilization as a function of recovery status following chemical addictions treatment. Journal of Addictive Diseases. 12:1993;97-108.
37. Horgan, C., Marsdan, M., & Larson, M.J. (1993). Substance abuse: The nation's number one health problem - Key indicators for policy. Institute for Health Policy, Brandeis University. Princeton, NJ: Robert Wood Johnson Foundation.
38. Hubbard R.L., Marsden M.E., Rachal J.V., Harwood H.J., Cavanaugh E.R., Ginzburg H.M. Drug abuse treatment. A national study of effectiveness:1989;University of North Carolina Press, Chapel Hill, NC.
39. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey Archives of General Psychiatry. 51:1994;8-19.
40. Kraft M.K., Rothbard A.B., Hadley T.R., McLellan A.T., Asch D.A. Are supplementary services provided during methadone maintenance really cost-effective? American Journal of Psychiatry. 154:1997;1214-1219.
41. Levin S.M., Trumble J.G., Edmunds M., Statman J.M., Petersen R.C. Perspectives on linkage of primary health care and substance abuse treatment. Journal of Addictive Diseases. 12:1993;1-8.
42. MacGowan R.J., Swanson N.M., Brackbill R.M., Rugg D.L., Barker T., Molde S. Retention in methadone maintenance treatment programs, Connecticut and Massachusetts, 1990-1993. Journal of Psychoactive Drugs. 28:1996;259-265.
43. Maddux F.F., Desmond D.P., Esquivel M. Rapid admission and retention on methadone. American Journal of Drug and Alcohol Abuse. 21:1995;533-547.
44. McDuff D.R., Solounias B.L., Beuger M., Cohen A., Klecz M., Weintraub E. Enhancing the care of hospitalized substance abusers and providing training in addiction psychiatry. The American Journal on Addictions. 6:1997;256-265.
45. McLellan A.T., Arndt I.O., Metzger D.S., Woody G.E., O'Brien C.P. The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association. 269:1993;1953-1959.
46. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth addition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 9:1992;199-213.
47. McLellan A.T., Luborsky L., O'Brien C.P., Woody G. An improved evaluation instrument for substance abuse patients. The Addiction Severity Index Journal of Nervous and Mental Diseases. 168:1980;26-33.
48. Meandzija B., O'Connor P.G., Fitzgerald B., Rounsaville B.J., Kosten T.R. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug and Alcohol Dependence. 36:1994;109-113.
49. Metzger D.S., Woody G.E., McLellan A.T., O'Brien C.P., Druley P., Navaline H., DePhilippis D., Stolley P., Abrutyn E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment. An 18-month follow-up Journal of Acquired Immune Deficiency Syndrome. 6:1993;1049-1056.
50. Moore R.D., Hidalgo J., Sugland B.W., Chaisson R.E. Zidovudine and the natural history of the Acquired Immunodeficiency Syndrome. The New England Journal of Medicine. 324:1991;1412-1416.
51. Office of Technology Assessment The effectiveness of drug abuse treatment: Implications for controlling AIDS/HIV infection (GPO#052-00). 1990;U.S. Government Printing Office, Washington, DC.
52. Pankratz L., Jackson J. Habitually wandering patients. The New England Journal of Medicine. 331:1994;1752-1755.
53. Pieper B. A retrospective analysis of venous ulcer healing in current and former users of injected drugs. Journal of Wound, Ostomy, and Continence Nursing. 23:1996;291-296.
54. Prochaska J.O., DiClemente C.C., Norcross J.C. In search of how people change. Applications to addictive behaviors. American Psychologist. 47:1992;1102-1114.
55. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association. 264:1990;2511-2518.
56. Samet J.H., Saitz R., Larson M.J. A case for enhanced linkage of substance abusers to primary medical care. Substance Abuse. 17:1996;181-192.
57. Saxon A.J., Wells E.A., Fleming C., Jackson T.R., Calsyn D.A. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction. 91:1996;1197-1209.
58. Schlenger W.E., Kroutl L.A., Roland E.J. Case management for linking drug abuse treatment and primary care: Preliminary evidence from the ADAMHA/HRSA linkage demonstration. Progress and Issues in Case Management (DHHS Publication No. 92-1946). 1992;U.S. Department of Health and Human Services, Rockville, MD.
59. Selwyn P. The impact of HIV infection on medical services in drug abuse treatment programs. Journal of Substance Abuse Treatment. 13:1996;397-410.
60. Selwyn P.A., Feingold A.R., Iezza A., Satyadeo M., Colley J., Jorres R., Shaw J.F.M. Primary care for patients with human immunodefiency virus (HIV) infection on a methadone maintenace treatment program. Annals of Internal Medicine. 110:1989;761-763.
61. Serpelloni G., Carrieri M.P., Rezza G., Morganti S., Gomma M., Binkin N. Methadone treatment as a determinant of HIV risk reduction among injecting drug users. A nested case-control study AIDS Care. 6:1994;215-220.
62. Shore R.E., Marmor M., Titus S., Des Jarlais D.C. Methadone maintenance and other factors associated with intraindividual temporal trends in injection-drug use. Journal of Substance Abuse Treatment. 13:1996;241-248.
63. Soderstrom C.A., Dischinger P.C., Smith G.S., McDuff D.R., Hebel J.R., Gorelick D.A. Psychoactive substance dependence among trauma center patients. Journal of the American Medical Association. 267:1992;2756-2759.
64. Spijkerman I.J.B., van Ameijden E.J.C., Mientjes G.H.C., Coutinho R.A., van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injecting drug users. Journal of Clinical Epidemiology. 49:1996;1149-1154.
65. Stark M.J. Dropping out of substance abuse treatment. A clinically oriented review Clinical Psychology Review. 12:1992;93-116.
66. Stein M.D. Medical complications of intravenous drug use. Journal of General Internal Medicine. 5:1990;249-257.
67. Stein M.D., Samet J.H., O'Conner P.G. The linkage of primary care services with substance abuse treatment. New opportunities for academic generalists Journal of General Internal Medicine. 8:1993;106-107.
68. Tumbarello M., Tacconelli E., Lucia M.B., Cauda R., Ortona L. Predictors of Staphylococcus aureus pneumonia associated with human immunodeficiency virus infection. Respiratory Medicine. 90:1996;531-537.
69. Umbricht-Schneiter A., Ginn D.H., Pabst D.M., Bigelow G.E. Providing medical care to methadone clinic patients. Referral vs. on-site care American Journal of Public Health. 84:1994;207-210.
70. Wells E.A., Calsyn D.A., Clark L.L., Saxon A.J., Jackson T.R. Retention in methadone maintenance is associated with reductions in different HIV risk behaviors for women and men. The American Journal of Drug and Alcohol Abuse. 22:1996;509-521.
71. White A.G. Medical disorders in drug addicts. 200 consecutive admissions Journal of the American Medical Association. 1223:1973;1469-1471.
72. White J.M., Ryan C.F., Ali R.L. Improvements in retention rates and changes in client group with methadone maintenance streaming. Drug and Alcohol Review. 15:1996;83-88.